Press Release TNC Investors Have Opportunity to Join Tennant Company Fraud Investigation with the Schall Law Firm 1 March 2026
Press Release GOSS Investors Have Opportunity to Join Gossamer Bio, Inc. Fraud Investigation with the Schall Law Firm 1 March 2026
Press Release DNOW Investors Have Opportunity to Join DNOW Inc. Fraud Investigation with the Schall Law Firm 1 March 2026
Press Release Public Storage and Welltower Announce Strategic Data Science Partnership to Advance Application of AI in Real Estate Investing 1 March 2026
Press Release TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing 1 March 2026
Press Release VZLA Investors Have Opportunity to Join Vizsla Silver Corp. Fraud Investigation with the Schall Law Firm 1 March 2026
Press Release SEVN Investors Have the Opportunity to Join Investigation of Seven Hills Realty Trust with the Schall Law Firm 1 March 2026
Press Release KORE Investors Have the Opportunity to Join Investigation of KORE Group Holdings, Inc. with the Schall Law Firm 1 March 2026
Press Release AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm 28 February 2026
Press Release KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC) 28 February 2026
